Melbourne, FL, August 10, 2013 --(PR.com
)-- Medicomp, Inc. (www.medicompinc.com), introduces the SAVI Air, the only Wireless Event Monitor to offer beat-to-beat analysis of the entire ECG, a patented feature previously unavailable to healthcare.
“What makes the SAVI Air wireless event monitor truly stand out is our Diogenes algorithm, which resides on our entire line of monitors and is widely regarded as the most advanced artificial intelligence technology in the industry,” says Dan Balda, M.D., Medicomp CEO.
Prior to the release of the SAVI Air, wireless event monitors relied on algorithms that could only analyze limited aspects of the ECG, therefore increasing the risk of missing significant arrhythmias.
The Diogenes algorithm is the only ambulatory cardiac monitoring technology to offer Rate, Rhythm, Morphology, and P-wave analysis. “No other company’s monitors provide this same complete analysis,” says Dr. Balda. “We know because we have the patent.”
The SAVI Air provides all the benefits and convenience of a wireless event monitor with the highest clinical yield available allowing for faster diagnosis and treatment.
Physicians no longer have to compromise on different standards of care with SAVI Air added to Medicomp’s product line. Physicians now have the ability to choose the cardiac monitor most suited for the individual needs of patients.
For more information, visit www.medicompinc.com or call (321) 821-2060.
About Medicomp, Inc.
Founded in 1981, Medicomp designs, develops and provides advanced cardiac monitoring products and services -- including Mobile Cardiac Telemetry, Holter, Event, and AF Burden Monitoring -- utilizing the most sophisticated and reliable ambulatory heart-monitoring systems in the world. Medicomp has been a technology leader in the telemedicine industry. Medicomp is dedicated to research, participating in multiple clinical trials around the globe. Medicomp is led by Dan Balda, M.D. As CEO, he utilizes his medical experience to guide the company with a physician’s perspective in caring for patients. For more information, visit www.medicompinc.com.